| abstract |
The present invention discloses the use of a compound for treating a disease caused by bacterial glucuronidase, said compound being an aspartame, a metabolite thereof or a pharmaceutically acceptable salt of said compound. The compound can be used for the treatment of cancer, diarrhea caused by irinotecan, relief of gastric ulcer caused by nonsteroidal anti-inflammatory drugs, or control of treatment efficacy and side effects of drugs that have undergone metabolism of bacterial glucuronidase, and bacterial glucuro It can also be used for related diseases caused by nidase. |